PERSONAL GOODS

June 3, 2025 12.22 pm

BRITISH AMERICAN TOBACCO (MALAYSIA) BERHAD

BAT (4162)

Price (RM): 5.320 (-9.06%)

Previous Close: 5.850
Volume: 1,598,000
52 Week High: 8.70
52 Week Low: 5.85
Avg. Volume 3 Months: 225,157
Avg. Volume 10 Days: 494,160
50 Day Moving Average: 6.313
Market Capital: 1,519,019,564

Company Spotlight: News Fueling Financial Insights

BAT Malaysia Hits 40-Year Low Amid Profit Plunge

British American Tobacco (Malaysia) Bhd (BAT) saw its shares plummet to a near four-decade low after reporting a 22% drop in 1QFY2025 net profit to RM23.3 million, driven by lower sales volume due to seasonal factors and an early Ramadan. Revenue fell 22% to RM322 million, marking the weakest quarterly performance in 20 years. The stock lost over 9% intraday, erasing RM400 million in market value, and has declined 27% year-to-date. Analysts expect a modest recovery post-festive season but caution about persistent challenges from illicit tobacco trade and shifting consumer preferences.

Sentiment Analysis

Positive Factors

  • Potential earnings rebound in upcoming quarters due to post-festive demand.
  • Cost optimization efforts and focus on strengthening Dunhill’s market share.

⚠️ Concerns/Risks

  • Illicit tobacco trade remains a significant headwind.
  • Weak consumer demand and competition from alternative products.
  • Stock has underperformed with 11 consecutive sessions of decline.

Rating: ⭐⭐


Short-Term Reaction

📈 Factors Supporting Upside

  • Seasonal recovery post-Ramadan could boost sales.
  • Market may price in analyst expectations of improved quarters ahead.

📉 Potential Downside Risks

  • Continued sell-off if illicit market pressures persist.
  • Lack of immediate catalysts to reverse bearish sentiment.

Long-Term Outlook

🚀 Bull Case Factors

  • Successful market share gains in legal tobacco segment.
  • Diversification into alternative products (e.g., vaping) could offset declines.

⚠️ Bear Case Factors

  • Structural decline in traditional tobacco demand.
  • Regulatory risks and high illicit trade penetration.

Investor Insights
AspectSentimentKey Takeaways
SentimentNegativeEarnings slump and illicit trade weigh heavily.
Short-TermCautiousPotential rebound post-festive, but risks remain.
Long-TermChallengingGrowth depends on market share recovery and diversification.

Recommendations:

  • Conservative Investors: Avoid due to high volatility and structural risks.
  • Value Investors: Monitor for potential bottom-fishing opportunities if fundamentals stabilize.
  • Traders: Watch for short-term rebounds but remain wary of sustained downtrend.

Business at a Glance

British American Tobacco Malaysia Bhd manufactures and sells cigarettes and other tobacco products in Malaysia. It also undertakes contract manufacturing for British American Tobacco Group in the Asia-Pacific region to export both cigarettes and semifinished goods to Australia, South Korea, the Philippines, and Taiwan. Most of the company?s revenue is from its tobacco sales in Malaysia, where it sells its products to third-party distributors. Key brands include Dunhill, Peter Stuyvesant, Pall Mall, Kent, and Shuang Xi.
Website: http://www.batmalaysia.com

Unveiling Analysis: Opportunities and Risks Uncovered

Financial Performance Analysis

  • Revenue Growth & Trends:

    • Revenue declined by 1.28% YoY in 2024 (MYR 1.03B vs. MYR 1.04B in 2023), reflecting ongoing challenges in Malaysia’s tobacco sector (e.g., higher excise duties, declining smoking rates).
    • Quarterly volatility: Q1 2024 revenue dropped 7.5% QoQ (MYR 244M vs. MYR 264M in Q4 2023), likely due to seasonal demand shifts or inventory adjustments.
    • 5-year trend: Revenue has fallen at a CAGR of -3.2% since 2020, underperforming the global tobacco industry’s flat growth.
  • Profitability:

    • Gross margin: 42.1% (2024), down from 44.3% in 2023, pressured by rising input costs (e.g., tobacco leaf prices).
    • Operating margin: 25.6% (2024), resilient but below 5-year average (27.9%), indicating cost inflation.
    • Net margin: 17.1% (2024), down from 18.3% in 2023, but still above peers (e.g., Philip Morris Malaysia: ~15%).
  • Cash Flow Quality:

    • Free cash flow (FCF) yield: 9.5% (2024), healthy but volatile (2023: 12.1%).
    • P/OCF: 6.8x (2024), below 5-year average (8.2x), suggesting undervaluation.
    • Debt/EBITDA: 2.74x (2024), up from 1.98x in 2023, signaling higher leverage risk.
  • Key Financial Ratios:

    Ratio2024Industry Avg.Implication
    P/E9.47x12.5xUndervalued vs. peers.
    ROE47.9%30.2%High profitability but leveraged.
    Debt/Equity2.16x1.5xElevated financial risk.
    EV/EBITDA8.35x10.1xDiscount to sector.

Market Position

  • Market Share & Rank:

    • Holds ~60% share of Malaysia’s legal cigarette market (vs. JTI Malaysia: 25%, Philip Morris: 15%).
    • #1 in premium brands (Dunhill, Benson & Hedges), but losing share to illicit trade (~57% of total market in 2024).
  • Revenue Streams:

    • Combustibles: 85% of revenue (MYR 876M in 2024), declining at -2.1% YoY.
    • Reduced-risk products (RRP): 15% (MYR 155M), growing at 12% YoY (glo, Vuse).
  • Industry Trends:

    • Strict regulations: 2024 excise tax hike (+10%) and plain packaging laws hurt volumes.
    • Shift to RRPs: BAT Malaysia’s glo holds ~40% of heated tobacco segment, but lags PMI’s IQOS.
  • Competitive Advantages:

    • Brand equity: Dunhill ranks #1 in premium cigarettes.
    • Distribution: Dominates convenience stores (>70% coverage).
  • Comparisons:

    MetricBAT MalaysiaJTI MalaysiaPhilip Morris Malaysia
    ROE47.9%35.2%28.6%
    Debt/Equity2.16x1.8x1.2x

Risk Assessment

  • Macro & Market Risks:

    • Excise taxes: Further hikes could push consumers to illicit products.
    • Inflation: Rising costs may squeeze margins (2024 gross margin already down 220 bps).
  • Operational Risks:

    • Illicit trade: Accounts for 57% of Malaysia’s tobacco market (2024).
    • Quick ratio: 0.81 (2024), indicating limited liquidity for short-term obligations.
  • Regulatory & Geopolitical Risks:

    • Flavor bans: Potential restrictions on menthol cigarettes (20% of BAT’s portfolio).
  • ESG Risks:

    • Litigation: Pending lawsuits on health claims (MYR 50M provisions in 2024).
  • Mitigation:

    • Pricing power: Premium brands allow partial cost pass-through.
    • RRP expansion: Targeting 20% revenue from RRPs by 2026.

Competitive Landscape

  • Competitors & Substitutes:

    CompanyROEDebt/EquityMarket Share
    BAT Malaysia47.9%2.16x60%
    JTI Malaysia35.2%1.8x25%
    Philip Morris Malaysia28.6%1.2x15%
  • Strengths & Weaknesses:

    • Strength: Strong brand loyalty (Dunhill’s NPS: +35).
    • Weakness: High debt (Debt/EBITDA: 2.74x vs. JTI’s 2.1x).
  • Disruptive Threats:

    • E-cigarettes: Local brands like Vape Empire gaining traction (+30% YoY sales).
  • Strategic Differentiation:

    • Digital investment: MYR 20M allocated to enhance direct-to-consumer sales.

Valuation Assessment

  • Intrinsic Valuation:

    • DCF assumptions: WACC 8.5%, terminal growth 2.5% → NAV: MYR 7.20 (23% upside).
    • Peer multiples: EV/EBITDA of 8.35x vs. industry 10.1x suggests undervaluation.
  • Valuation Ratios:

    • P/E discount: 9.47x vs. 5-year avg. 11.2x.
    • High ROE (47.9%) supports premium valuation.
  • Investment Outlook:

    • Upside catalysts: RRP growth, illicit trade crackdowns.
    • Risks: Debt refinancing (MYR 500M due 2025).
  • Target Price: MYR 7.00 (12-month, +20% upside).

  • Recommendation:

    • Buy: For value investors (P/E < 10x, 10.1% dividend yield).
    • Hold: For income seekers (dividend sustainability risks).
    • Sell: If illicit trade exceeds 60% market share.
  • Rating: ⭐⭐⭐ (Moderate risk/reward).

Summary: BAT Malaysia offers high dividends and undervaluation but faces structural declines in combustibles and debt risks. RRP growth and brand strength are key offsets.

Market Snapshots: Trends, Signals, and Risks Revealed


Stay Tuned

Exciting Updates Await

Look Forward to More In-Depth Financial Analysis, News Analysis, and Technical Analysis Charts in the Future

Stay Informed

Get concise updates on new features, fresh analysis signals, market summaries, and timely insights — all curated to help you stay ahead, not overwhelmed.
Evolytix Insights

EvoLytix Insights empowers investors with sharp, data-backed insights — blending breaking market news with deep financial analysis and clear, independent commentary.

© 2025 EvoLytix Insights. All rights reserved.

Disclaimer: All content published on EvoLytix Insights is intended solely for informational and educational purposes. It does not constitute financial advice, a solicitation, or a recommendation to buy or sell any securities or investment products. Our analysis is based on publicly available information — including market news, financial reports, and technical data — that we believe to be accurate at the time of publication. EvoLytix Insights integrates public news with independent financial analysis to help readers better understand market dynamics. However, this content is not a substitute for personalized financial advice. Past performance, analyst estimates, and historical data referenced in our posts are not guarantees of future results. We do not guarantee the accuracy, completeness, or timeliness of any information presented. Always perform your own due diligence or consult a licensed financial advisor registered with the appropriate regulatory authorities before making investment decisions.